AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28404091
Drug: Tenofovir alafenamide
RxNorm normalized name: Tenofovir Alafenamide
DrugBank: Tenofovir alafenamide (DB09299)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tenofovir alafenamide (25 mg)
Trial: 24385121
Drug: 5-aminolevulonic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-aminolevulonic acid (ALA) photodynamic therapy (PDT), two treatments, 2 weeks apart
Trial: 24385121
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group observed without treatment
Trial: 9397291
Drug: Calcium antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonist treatment
Trial: 8394193
Drug: felodipine-ER (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: felodipine-ER (5 to 20 mg once daily)
Trial: 26604731
Drug: Erdosteine (ER)
RxNorm normalized name: erdosteine
DrugBank: Erdosteine (DB05057)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erdosteine (ER) 900 mg daily
Trial: 21870121
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g ALC twice a day for 90 days
Trial: 10971236
Drug: Mesalazine foam
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mesalazine foam enema (2 g per day)
Trial: 1799929
Drug: Bisoprolol (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol (various doses)
Trial: 1799929
Drug: Enalapril and
RxNorm normalized name: enalapril and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril and hydrochlorothiazide combination
Trial: 6381336
Drug: Chlorimipramine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorimipramine (50 mg/day) + L-5-HTP (300 mg/day)
Trial: 6381336
Drug: Chlorimipramine +
RxNorm normalized name: Chlorimipramine
DrugBank: Clomipramine (DB01242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorimipramine + L-5-HTP
Trial: 19682769
Drug: Topical bexarotene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical bexarotene 1% gel applied twice daily for 6 months
Trial: 17577801
Drug: Bupropion (BUP)
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion (BUP) with standard cognitive-behavioral smoking cessation treatment (ST)
Trial: 17577801
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment for depression (CBTD) with BUP
Trial: 17577801
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment for depression (CBTD) with placebo (PLAC)
Trial: 17577801
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (ST) plus placebo (PLAC)
Trial: 9650013
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 600 mg t.i.d. and sodium selenite (Se) 500 micrograms per day for 24 weeks (group A)
Trial: 30617431
Drug: Life review
RxNorm normalized name: Life-O-Gen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Life review therapy combined with memory specificity training (LRT-MST)
Trial: 28065679
Drug: BDP/FF DPI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BDP/FF DPI 200/12 μg
Trial: 28065679
Drug: BDP/FF DPI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BDP/FF DPI 800/48 μg
Trial: 28065679
Drug: BDP/FF pMDI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BDP/FF pMDI 200/12 μg
Trial: 28065679
Drug: BDP/FF pMDI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BDP/FF pMDI 800/48 μg
Trial: 21507074
Drug: Low-frequency ultrasound
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-frequency ultrasound (US) at 36 kHz for 5 min, dosage from 1.57 to 3.50 W/cm(2)
Trial: 17628185
Drug: Vitamin E-based
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E-based compounds
Trial: 15530579
Drug: Computerized pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computerized pill bottles
Trial: 2195580
Drug: Caffeine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (150 mg in decaffeinated coffee)
Trial: 28657933
Drug: Glucocorticoid low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucocorticoid low dose (≤9 mg·kg prednisone)
Trial: 28657933
Drug: Glucocorticoid high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucocorticoid high dose (>9 mg·kg prednisone)
Trial: 24461664
Drug: Azithromycin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (30 mg/kg once a week for up to 24 months)
Trial: 21723353
Drug: Different doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different doses of IXIARO
Trial: 15631874
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine (17.5 mg)
Trial: 15631874
Drug: Fluoxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20 mg/day, 5 days weekly for 6 months, 3 days weekly at month 7 and 1 day/week at month 8)
Trial: 15631874
Drug: Both nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both nicotine and fluoxetine
Trial: 11334145
Drug: LR‐3280 (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LR‐3280 (doses from 1 to 24 mg) administered into target vessel through a guiding catheter
Trial: 9327151
Drug: Doxorubicin 10
RxNorm normalized name: DOXOrubicin 10 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 10 mg/m2 every 2 weeks with bleomycin 10 U/m2 and vincristine 1.4 mg/m2, zidovudine 100 mg five times daily, and rhGM-CSF 5 micrograms/kg/day
Trial: 9327151
Drug: rhGM-CSF at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhGM-CSF at doses of 2.5 to 5 micrograms/kg
Trial: 9327151
Drug: Doxorubicin 20
RxNorm normalized name: DOXOrubicin 20 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 20 mg/m2
Trial: 2576359
Drug: Picumast dihydrochloride
RxNorm normalized name: Levocetirizine Dihydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picumast dihydrochloride (10 mg)
Trial: 2576359
Drug: Theophylline (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (7 mg/kg b.w.)
Trial: 2576359
Drug: Picumast dihydrochloride
RxNorm normalized name: Levocetirizine Dihydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picumast dihydrochloride (10 mg) and Theophylline (7 mg/kg b.w.) combined
Trial: 1105483
Drug: Prazosin 5
RxNorm normalized name: prazosin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin 5 mg three or four times a day
Trial: 1105483
Drug: Prazosin in
RxNorm normalized name: Product containing prazosin in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin in combination with polythiazide
Trial: 19424085
Drug: Galantamine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine (8 mg/day for 4 weeks then 16 mg/day for another 4 weeks)
Trial: 9230143
Drug: Controlled-release niacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release niacin
Trial: 8477561
Drug: Captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50 mg/day for 5 days)
Trial: 28468642
Drug: Short cognitive
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short cognitive behavioural therapy (CBT)-based treatment by mental health nurse practitioners (MHNPs) in addition to usual GP care
Trial: 28468642
Drug: Short cognitive
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short cognitive behavioural therapy (CBT)-based treatment by MHNPs
Trial: 21978713
Drug: Oral desensitisation
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral desensitisation with cow's milk
Trial: 21978713
Drug: Oral desensitisation
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral desensitisation with hen's egg
Trial: 21978713
Drug: Oral desensitisation
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral desensitisation with cow's milk and hen's egg
Trial: 21978713
Drug: Oral desensitisation
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral desensitisation with raw hen's egg
Trial: 16612399
Drug: Prophylactic administration
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic administration of antioxidant compounds, such as acetylcysteine and ascorbic acid
Trial: 8612383
Drug: Buccal mode
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal mode inhalation technique
Trial: 8612383
Drug: Pulmonary mode
RxNorm normalized name: Lobaria pulmonaria extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulmonary mode inhalation technique
Trial: 6141436
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy every 8 weeks for 2 years
Trial: 30238584
Drug: Tacrolimus ointment
RxNorm normalized name: Tacrolimus Ointment
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus ointment plus 308 nm excimer lamp
Trial: 30238584
Drug: Tacrolimus ointment
RxNorm normalized name: Tacrolimus Ointment
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus ointment plus 308 nm excimer lamp plus fractional CO2 laser
Trial: 25119339
Drug: Iron supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplements (0 mg/kg/d)
Trial: 25119339
Drug: Iron supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplements (1 mg/kg/d)
Trial: 25119339
Drug: Iron supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplements (2 mg/kg/d)
Trial: 20488346
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT), 10 sessions
Trial: 18833859
Drug: Group 1:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1: Intact teeth (no preparation)
Trial: 11838889
Drug: Food service
RxNorm normalized name: BENZALKONIUM CHLORIDE 0.13 in 1 mL TOPICAL SOAP [RD Food Service DBA Restaurant Depot]
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Food service intervention (training workshops for cooks and monthly site visits)
Trial: 10367619
Drug: Cytokine production
RxNorm normalized name: cytosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine production of G-CSF
Trial: 1981698
Drug: 0.50 mg
RxNorm normalized name: EVEROLIMUS 0.50 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.50 mg etizolam
Trial: 1981698
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg etizolam
Trial: 28414728
Drug: Injection-naïve children
RxNorm normalized name: Pediaclear Childrens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection-naïve children with clown-care
Trial: 19961603
Drug: Physiotherapy, corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy, corticosteroid injection, and naproxen
Trial: 19961603
Drug: Physiotherapy, placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy, placebo injection, and naproxen
Trial: 19961603
Drug: Wait and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wait and see treatment with naproxen alone
Trial: 15128682
Drug: Empirical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical treatment with omeprazole and serological H.pylori testing
Trial: 9566670
Drug: Low-dose prednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prednisolone (average 6.0+/−0.2 mg daily)
Trial: 8313822
Drug: Erythromycin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (150 mg)
Trial: 24751173
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment control (coaches who did not receive coach education sessions)
Trial: 23517933
Drug: Adalimumab induction
RxNorm normalized name: adalimumab Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab induction (160/80 mg)
Trial: 23517933
Drug: Adalimumab maintenance
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adalimumab maintenance (40 mg every-other-week)
Trial: 22319691
Drug: Steroid-antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-antibiotic
Trial: 18466276
Drug: Microwave disinfection
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Microwave disinfection + topical miconazole (three times per day for 30 days)
Trial: 18466276
Drug: Topical miconazole
RxNorm normalized name: miconazole Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical miconazole (three times per day for 30 days)
Trial: 10960945
Drug: Paclitaxel (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (200 mg/m2 i.v. 3-hour infusion on day 1) + Carboplatin (AUC 6)
Trial: 10960945
Drug: Paclitaxel (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (200 mg/m2 i.v. 3-hour infusion on day 1) + Gemcitabine (1,000 mg/m2 on days 1 and 8)
Trial: 2419693
Drug: Pafenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pafenolol 50 mg once daily
Trial: 2419693
Drug: Pafenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pafenolol 100 mg once daily
Trial: 27444425
Drug: Integrated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated treatment (Motivational Enhancement Therapy and Prolonged Exposure delivered concurrently)
Trial: 27444425
Drug: Sequential treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential treatment (Motivational Enhancement Therapy and Prolonged Exposure delivered sequentially)
Trial: 25261164
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (25 μg/d)
Trial: 31365099
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (10 μg/d)
Trial: 20543019
Drug: Traditional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional therapy plus proprioceptive neuromuscular facilitation plus neuromobilization (Experimental group 2)
Trial: 20543019
Drug: Traditional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional therapy plus proprioceptive neuromuscular facilitation (Experimental group 1)
Trial: 20543019
Drug: Traditional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional therapy (Control group)
Trial: 19115912
Drug: Acetazolamide 250
RxNorm normalized name: acetazolamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide 250 mg/day (125 mg bid)
Trial: 12939216
Drug: Aspirin (325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (325 mg on alternate days)
Trial: 6383614
Drug: Long-term drug
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term drug therapy (cyclophosphamide)
Trial: 6383614
Drug: Short-term drug
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term drug therapy (cyclophosphamide)
Trial: 31860203
Drug: Standard low-calorie
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard low-calorie diet (1730 kcal, protein - 87.4 g, fat - 61.4 g, carbohydrates - 207 g)
Trial: 31860203
Drug: Personalized diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalized diet (2125 kcal, protein - 100.2 g, fat - 75.9 g, carbohydrates - 260 g) with modification of protein component
Trial: 29069507
Drug: Mavrilimumab (30,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mavrilimumab (30, 100 or 150 mg)
Trial: 29069507
Drug: Mavrilimumab (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mavrilimumab (150 mg)
Trial: 19580457
Drug: Intensive bisphosphonate
RxNorm normalized name: methylene diphosphonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive bisphosphonate therapy
Trial: 9472182
Drug: Ipratropium plus
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium plus albuterol (initial dose of albuterol 2.5 mg followed by 2 more doses at 20-min intervals, ipratropium 0.5 mg combined with the initial dose of albuterol)
Trial: 9472182
Drug: Albuterol alone
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol alone (2.5 mg initial dose followed by 2 more doses at 20-min intervals)
Trial: 8585220
Drug: Wobe-Mugos (tablets)
RxNorm normalized name: pine needle oil (pinus mugo)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wobe-Mugos (tablets)
Trial: 2504075
Drug: Midazolam (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.4 mg/kg) and Innovar (0.04 ml/kg)
Trial: 2504075
Drug: Chlorprothixene (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorprothixene (2.0 mg/kg)
Trial: 1091393
Drug: Pentobarbital 60
RxNorm normalized name: pentobarbital 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentobarbital 60 mg
Trial: 1091393
Drug: Pentobarbital 180
RxNorm normalized name: Pentobarbital
DrugBank: Pentobarbital (DB00312)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentobarbital 180 mg
Trial: 1091393
Drug: Diphenhydramine 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 150 mg
Trial: 1091393
Drug: Methapyrilene 50
RxNorm normalized name: methapyrilene
DrugBank: Methapyrilene (DB04819)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methapyrilene 50 mg
Trial: 6928183
Drug: Pentobarbital 100
RxNorm normalized name: pentobarbital 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentobarbital 100 mg
Trial: 28049480
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy rehabilitation program with coaching based on cognitive behavioral therapy (CBT) principles (OTc)
Trial: 28049480
Drug: Sensor monitoring
RxNorm normalized name: aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sensor monitoring added to the occupational therapy intervention (OTcsm)
Trial: 19016463
Drug: Narrow-band blue-light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrow-band blue-light therapy
Trial: 19016463
Drug: Red-light therapy
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red-light therapy (control)
Trial: 16510061
Drug: H2RAs or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2RAs or PPIs (maintenance therapy)
Trial: 10553391
Drug: Conventional postlicensing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional postlicensing treatment program (control)
Trial: 6412733
Drug: Alaproclate combined
RxNorm normalized name: alaproclate
DrugBank: Alaproclate (DB13233)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alaproclate combined with morphine
Trial: 6412733
Drug: Morphine i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine i.v.
Trial: 22000309
Drug: Phenytoin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin (20 mg/kg)
Trial: 30516574
Drug: Mirtazapine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine (30 mg/d)
Trial: 27873545
Drug: Probiotic lozenges
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic lozenges containing Lactobacillus reuteri
Trial: 19944452
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with paclitaxel and carboplatin (58% underwent three cycles, 42% had six cycles)
Trial: 16082607
Drug: Mini-dose aprotinin
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mini-dose aprotinin (500.000 KIU [70 mg] in the pump)
Trial: 10223359
Drug: Antibiotic prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prophylaxis with 2 g cefotaxime
Trial: 10223359
Drug: Antibiotic prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prophylaxis with 4g piperacillin plus 0.5g tazobactam
Trial: 21997545
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin with colonoscopy screening
Trial: 21997545
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin with sigmoidoscopy screening